Xconomy: Imperium Infused with $18M, Winshuttle Wins Over the French, the Top 10 Q3 Venture Deals, & More Seattle-Area Deals News
Summary
No blockbusters in the past week, but there was decent action in tech mergers and acquisitions, as well as funding of biotech and energy companies.—Electro Scientific Industries, a photonics company based in Portland, OR, is merging with Middlefield, CT-based Zygo, a metrology and optics firm, in an all-stock transaction.—Micronics, a Redmond, WA, maker of molecular diagnostics and monitoring tools, closed a Series C financing round led by the Southwest Michigan First Life Science Fund.—Seattle Genetics, a Bothell, WA, developer of targeted cancer drugs, received a milestone payment from Progenics Pharmaceuticals, as Luke reported.Progenics bought a license to the Seattle Genetics technology and has used it to develop a drug candidate that is in clinical trials for hormone-resistant prostate cancer.
Classifications
AskAI Classifications
LabelsLinked Companies
